News Update: What You Need to Know About the Court Case Attacking Access to Mifepristone in the United States
Name of the Case: Alliance for Hippocratic Medicine et al. v. U.S. Food and Drug Administration et al.
This update outlines what you need to know about the court case attacking access to mifepristone, one of two drugs most commonly used in medication abortion in the United States, as of October 2023. It describes what has happened and what is at stake if the FDA approval for mifepristone is rescinded. This update also outlines potential implications globally and provides clear and actionable next steps to learn more about this case and monitor similar threats to abortion access in other country contexts.